139 related articles for article (PubMed ID: 2896637)
1. Applications of BOP reagent in solid phase synthesis. Advantages of BOP reagent for difficult couplings exemplified by a synthesis of [Ala 15]-GRF(1-29)-NH2.
Fournier A; Wang CT; Felix AM
Int J Pept Protein Res; 1988 Jan; 31(1):86-97. PubMed ID: 2896637
[TBL] [Abstract][Full Text] [Related]
2. BOP reagent for the coupling of pGlu and Boc-His(Tos) in solid phase peptide synthesis.
Forest M; Fournier A
Int J Pept Protein Res; 1990 Feb; 35(2):89-94. PubMed ID: 2323890
[TBL] [Abstract][Full Text] [Related]
3. Conformational origin of a difficult coupling in a human growth hormone releasing factor analog.
Deber CM; Lutek MK; Heimer EP; Felix AM
Pept Res; 1989; 2(2):184-8. PubMed ID: 2520756
[TBL] [Abstract][Full Text] [Related]
4. Repetitive BOP coupling (REBOP) in solid phase peptide synthesis. Luliberin synthesis as model.
Seyer R; Aumelas A; Caraty A; Rivaille P; Castro B
Int J Pept Protein Res; 1990 May; 35(5):465-72. PubMed ID: 2198236
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological activity and conformational analysis of cyclic GRF analogs.
Felix AM; Heimer EP; Wang CT; Lambros TJ; Fournier A; Mowles TF; Maines S; Campbell RM; Wegrzynski BB; Toome V
Int J Pept Protein Res; 1988 Dec; 32(6):441-54. PubMed ID: 3149952
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a hydrophilic affinity matrix for the purification of the vasoactive intestinal peptide receptor.
Fournier A; Couvineau A; Laburthe M
Anal Biochem; 1993 Jun; 211(2):305-10. PubMed ID: 8391225
[TBL] [Abstract][Full Text] [Related]
7. Asparagine coupling in Fmoc solid phase peptide synthesis.
Gausepohl H; Kraft M; Frank RW
Int J Pept Protein Res; 1989 Oct; 34(4):287-94. PubMed ID: 2599767
[TBL] [Abstract][Full Text] [Related]
8. Automated solid-phase peptide synthesis: use of 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate for coupling of tert-butyloxycarbonyl amino acids.
Reid GE; Simpson RJ
Anal Biochem; 1992 Feb; 200(2):301-9. PubMed ID: 1632494
[TBL] [Abstract][Full Text] [Related]
9. Analogues of growth hormone-releasing factor (1-29) amide containing the reduced peptide bond isostere in the N-terminal region.
Hocart SJ; Murphy WA; Coy DH
J Med Chem; 1990 Jul; 33(7):1954-8. PubMed ID: 2141879
[TBL] [Abstract][Full Text] [Related]
10. Semisynthesis of human growth hormone-releasing factor by trypsin catalyzed coupling of leucine amide to a C-terminal acid precursor.
Bongers J; Offord RE; Felix AM; Campbell RM; Heimer EP
Int J Pept Protein Res; 1992; 40(3-4):268-73. PubMed ID: 1478784
[TBL] [Abstract][Full Text] [Related]
11. Occurrence and Minimization of Cysteine Racemization during Stepwise Solid-Phase Peptide Synthesis(1)(,)(2).
Han Y; Albericio F; Barany G
J Org Chem; 1997 Jun; 62(13):4307-4312. PubMed ID: 11671751
[TBL] [Abstract][Full Text] [Related]
12. Studies on peptides. CXX. Synthesis of growth hormone releasing factor (GRF-37-NH2) and N alpha-biotinyl-GRF-44-NH2.
Fujii N; Shimokura M; Yajima H; Shono F; Tsuda M; Yoshitake A
Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):1200-8. PubMed ID: 6430578
[No Abstract] [Full Text] [Related]
13. Enzymatic semisynthesis of a superpotent analog of human growth hormone-releasing factor.
Bongers J; Lambros T; Liu W; Ahmad M; Campbell RM; Felix AM; Heimer EP
J Med Chem; 1992 Oct; 35(21):3934-41. PubMed ID: 1433202
[TBL] [Abstract][Full Text] [Related]
14. Semisynthesis of human growth hormone-releasing factors by alpha-amidating enzyme catalyzed oxidation of glycine-extended precursors.
Bongers J; Felix AM; Campbell RM; Lee Y; Merkler DJ; Heimer EP
Pept Res; 1992; 5(4):183-9. PubMed ID: 1421807
[TBL] [Abstract][Full Text] [Related]
15. Use of thiol acids in peptide segment coupling in non-aqueous solvents.
Yamashiro D; Blake J
Int J Pept Protein Res; 1981 Oct; 18(4):383-92. PubMed ID: 7309385
[TBL] [Abstract][Full Text] [Related]
16. In vitro stability of growth hormone releasing factor (GRF) analogs in porcine plasma.
Su CM; Jensen LR; Heimer EP; Felix AM; Pan YC; Mowles TF
Horm Metab Res; 1991 Jan; 23(1):15-21. PubMed ID: 1826667
[TBL] [Abstract][Full Text] [Related]
17. Selective coupling of methotrexate to peptide hormone carriers through a gamma-carboxamide linkage of its glutamic acid moiety: benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate activation in salt coupling.
Nagy A; Szoke B; Schally AV
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6373-6. PubMed ID: 8101004
[TBL] [Abstract][Full Text] [Related]
18. Comparison of enzymatic semisyntheses of peptide amides: human growth hormone releasing factor and analogs.
Bongers J; Offord RE; Felix AM; Lambros T; Liu W; Ahmad M; Campbell RM; Heimer EP
Biomed Biochim Acta; 1991; 50(10-11):S157-62. PubMed ID: 1820039
[TBL] [Abstract][Full Text] [Related]
19. Efficient solid phase peptide synthesis. Use of methanesulfonic acid alpha-amino deprotecting procedure and new coupling reagent, 2-(benzotriazol-1-yl)oxy-1,3-dimethylimidazolidinium hexafluorophosphate (BOI).
Kiso Y; Fujiwara Y; Kimura T; Nishitani A; Akaji K
Int J Pept Protein Res; 1992; 40(3-4):308-14. PubMed ID: 1335997
[TBL] [Abstract][Full Text] [Related]
20. Studies on sensitivity to racemization of activated residues in couplings of N-benzyloxycarbonyldipeptides.
Benoiton NL; Lee YC; Steinaur R; Chen FM
Int J Pept Protein Res; 1992 Dec; 40(6):559-66. PubMed ID: 1286941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
